Nichole A. Piece, RN, CCRC
See Publications

Texas Heart Institute Positions

Certifications

  • Certified Clinical Research Professional

Publications

4862227 MQ2VW9FC 1 alternatives-to-animal-experimentation 10 date desc Piece 2050 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22MQ4RVVPE%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Perin%20et%20al.%22%2C%22parsedDate%22%3A%222017-04-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPerin%2C%20E.%20C.%2C%20Murphy%2C%20M.%20P.%2C%20March%2C%20K.%20L.%20et%20al.%20%282017%29.%20Evaluation%20of%20cell%20therapy%20on%20exercise%20performance%20and%20limb%20perfusion%20in%20peripheral%20artery%20disease%3A%20the%20CCTRN%20PACE%20Trial%20%28Patients%20With%20Intermittent%20Claudication%20Injected%20With%20ALDH%20Bright%20Cells%29.%20%26lt%3Bi%26gt%3BCirculation%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B135%26lt%3B%5C%2Fi%26gt%3B%2C%201417%26%23x2013%3B1428.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.116.025707%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.116.025707%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluation%20of%20cell%20therapy%20on%20exercise%20performance%20and%20limb%20perfusion%20in%20peripheral%20artery%20disease%3A%20the%20CCTRN%20PACE%20Trial%20%28Patients%20With%20Intermittent%20Claudication%20Injected%20With%20ALDH%20Bright%20Cells%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emerson%20C.%22%2C%22lastName%22%3A%22Perin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20P.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22March%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roberto%22%2C%22lastName%22%3A%22Bolli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Loughran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Phillip%20C.%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20J.%22%2C%22lastName%22%3A%22Leeper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20L.%22%2C%22lastName%22%3A%22Dalman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Alexander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20D.%22%2C%22lastName%22%3A%22Henry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jay%20H.%22%2C%22lastName%22%3A%22Traverse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carl%20J.%22%2C%22lastName%22%3A%22Pepine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20David%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%22%2C%22lastName%22%3A%22Berceli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20T.%22%2C%22lastName%22%3A%22Willerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raja%22%2C%22lastName%22%3A%22Muthupillai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amir%22%2C%22lastName%22%3A%22Gahremanpour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ganesh%22%2C%22lastName%22%3A%22Raveendran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omaida%22%2C%22lastName%22%3A%22Velasquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Hare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivonne%22%2C%22lastName%22%3A%22Hernandez%20Schulman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijaykumar%20S.%22%2C%22lastName%22%3A%22Kasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20R.%22%2C%22lastName%22%3A%22Hiatt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bharath%22%2C%22lastName%22%3A%22Ambale-Venkatesh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%5Cu00e3o%20A.%22%2C%22lastName%22%3A%22Lima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doris%20A.%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Micheline%22%2C%22lastName%22%3A%22Resende%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%20P.%22%2C%22lastName%22%3A%22Gee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20G.%22%2C%22lastName%22%3A%22Durett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanette%22%2C%22lastName%22%3A%22Bloom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Richman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22G%27Sell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shari%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fouzia%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elsie%22%2C%22lastName%22%3A%22Gyang%20Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%20R.%22%2C%22lastName%22%3A%22Santoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JoAnne%22%2C%22lastName%22%3A%22Goldman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dana%22%2C%22lastName%22%3A%22Leach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eileen%22%2C%22lastName%22%3A%22Handberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Cheong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nichole%22%2C%22lastName%22%3A%22Piece%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darcy%22%2C%22lastName%22%3A%22DiFede%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barb%22%2C%22lastName%22%3A%22Bruhn-Ding%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Caldwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judy%22%2C%22lastName%22%3A%22Bettencourt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dejian%22%2C%22lastName%22%3A%22Lai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda%22%2C%22lastName%22%3A%22Piller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shelly%20L.%22%2C%22lastName%22%3A%22Sayre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20W.%22%2C%22lastName%22%3A%22Vojvodic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lem%22%2C%22lastName%22%3A%22Moy%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ray%20F.%22%2C%22lastName%22%3A%22Ebert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20D.%22%2C%22lastName%22%3A%22Simari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%20T.%22%2C%22lastName%22%3A%22Hirsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cardiovascular%20Cell%20Therapy%20Research%20Network%20%28CCTRN%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Atherosclerotic%20peripheral%20artery%20disease%20affects%208%25%20to%2012%25%20of%20Americans%20%26gt%3B65%20years%20of%20age%20and%20is%20associated%20with%20a%20major%20decline%20in%20functional%20status%2C%20increased%20myocardial%20infarction%20and%20stroke%20rates%2C%20and%20increased%20risk%20of%20ischemic%20amputation.%20Current%20treatment%20strategies%20for%20claudication%20have%20limitations.%20PACE%20%28Patients%20With%20Intermittent%20Claudication%20Injected%20With%20ALDH%20Bright%20Cells%29%20is%20a%20National%20Heart%2C%20Lung%2C%20and%20Blood%20Institute-sponsored%2C%20randomized%2C%20double-blind%2C%20placebo-controlled%2C%20phase%202%20exploratory%20clinical%20trial%20designed%20to%20assess%20the%20safety%20and%20efficacy%20of%20autologous%20bone%20marrow-derived%20aldehyde%20dehydrogenase%20bright%20%28ALDHbr%29%20cells%20in%20patients%20with%20peripheral%20artery%20disease%20and%20to%20explore%20associated%20claudication%20physiological%20mechanisms.%5CnMETHODS%3A%20All%20participants%2C%20randomized%201%3A1%20to%20receive%20ALDHbr%20cells%20or%20placebo%2C%20underwent%20bone%20marrow%20aspiration%20and%20isolation%20of%20ALDHbr%20cells%2C%20followed%20by%2010%20injections%20into%20the%20thigh%20and%20calf%20of%20the%20index%20leg.%20The%20coprimary%20end%20points%20were%20change%20from%20baseline%20to%206%20months%20in%20peak%20walking%20time%20%28PWT%29%2C%20collateral%20count%2C%20peak%20hyperemic%20popliteal%20flow%2C%20and%20capillary%20perfusion%20measured%20by%20magnetic%20resonance%20imaging%2C%20as%20well%20as%20safety.%5CnRESULTS%3A%20A%20total%20of%2082%20patients%20with%20claudication%20and%20infrainguinal%20peripheral%20artery%20disease%20were%20randomized%20at%209%20sites%2C%20of%20whom%2078%20had%20analyzable%20data%20%2857%20male%2C%2021%20female%20patients%3B%20mean%20age%2C%2066%5Cu00b19%20years%29.%20The%20mean%5Cu00b1SEM%20differences%20in%20the%20change%20over%206%20months%20between%20study%20groups%20for%20PWT%20%280.9%5Cu00b10.8%20minutes%3B%2095%25%20confidence%20interval%20%5BCI%5D%20-0.6%20to%202.5%3B%20P%3D0.238%29%2C%20collateral%20count%20%280.9%5Cu00b10.6%20arteries%3B%2095%25%20CI%2C%20-0.2%20to%202.1%3B%20P%3D0.116%29%2C%20peak%20hyperemic%20popliteal%20flow%20%280.0%5Cu00b10.4%20mL%5C%2Fs%3B%2095%25%20CI%2C%20-0.8%20to%200.8%3B%20P%3D0.978%29%2C%20and%20capillary%20perfusion%20%28-0.2%5Cu00b10.6%25%3B%2095%25%20CI%2C%20-1.3%20to%200.9%3B%20P%3D0.752%29%20were%20not%20significant.%20In%20addition%2C%20there%20were%20no%20significant%20differences%20for%20the%20secondary%20end%20points%2C%20including%20quality-of-life%20measures.%20There%20were%20no%20adverse%20safety%20outcomes.%20Correlative%20relationships%20between%20magnetic%20resonance%20imaging%20measures%20and%20PWT%20were%20not%20significant.%20A%20post%20hoc%20exploratory%20analysis%20suggested%20that%20ALDHbr%20cell%20administration%20might%20be%20associated%20with%20an%20increase%20in%20the%20number%20of%20collateral%20arteries%20%281.5%5Cu00b10.7%3B%2095%25%20CI%2C%200.1-2.9%3B%20P%3D0.047%29%20in%20participants%20with%20completely%20occluded%20femoral%20arteries.%5CnCONCLUSIONS%3A%20ALDHbr%20cell%20administration%20did%20not%20improve%20PWT%20or%20magnetic%20resonance%20outcomes%2C%20and%20the%20changes%20in%20PWT%20were%20not%20associated%20with%20the%20anatomic%20or%20physiological%20magnetic%20resonance%20imaging%20end%20points.%20Future%20peripheral%20artery%20disease%20cell%20therapy%20investigational%20trial%20design%20may%20be%20informed%20by%20new%20anatomic%20and%20perfusion%20insights.%5CnCLINICAL%20TRIAL%20REGISTRATION%3A%20URL%3A%20http%3A%5C%2F%5C%2Fwww.clinicaltrials.gov.%20Unique%20identifier%3A%20NCT01774097.%22%2C%22date%22%3A%22Apr%2011%2C%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCULATIONAHA.116.025707%22%2C%22ISSN%22%3A%221524-4539%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NNUFWYNJ%22%2C%22LPUKMNGT%22%2C%22CXMKC5YW%22%2C%228HHBIBI6%22%2C%22EA6QZY69%22%2C%22RJDC3SK5%22%2C%22MQ2VW9FC%22%2C%228PULYTSK%22%5D%2C%22dateModified%22%3A%222018-05-07T15%3A11%3A12Z%22%7D%7D%5D%7D
Perin, E. C., Murphy, M. P., March, K. L. et al. (2017). Evaluation of cell therapy on exercise performance and limb perfusion in peripheral artery disease: the CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells). Circulation 135, 1417–1428. https://doi.org/10.1161/CIRCULATIONAHA.116.025707.